Hisataka Ogawa
Overview
Explore the profile of Hisataka Ogawa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawa H, Yoshida K, Hasegawa S, Wada H, Yasui M, Tahara H
Front Oncol
. 2025 Mar;
15:1485886.
PMID: 40078183
Background: and preclinical examinations of cancer cell lines are performed to determine the effectiveness of new drugs before initiating clinical trials. However, there is often a significant disparity between the...
2.
SHARPIN Enhances Ferroptosis in Synovial Sarcoma Cells via NF-κB- and PRMT5-Mediated PGC1α Reduction
Tamiya H, Urushihara N, Shizuma K, Ogawa H, Nakai S, Wakamatsu T, et al.
Cancers (Basel)
. 2023 Jul;
15(13).
PMID: 37444594
Sarcoma is a rare type of cancer for which new therapeutic agents are required. Ferroptosis is a nonapoptotic cell death triggered by iron-mediated lipid peroxidation. We found that TFRC, an...
3.
Wakamatsu T, Ogawa H, Yoshida K, Matsuoka Y, Shizuma K, Imura Y, et al.
Front Oncol
. 2022 Jun;
12:893592.
PMID: 35677170
Background: Although biological resources are essential for basic and preclinical research in the oncological field, those of sarcoma are not sufficient for rapid development of the treatment. So far, some...
4.
Ikezawa K, Ekawa T, Hasegawa S, Kai Y, Takada R, Yamai T, et al.
Endosc Int Open
. 2022 Jan;
10(1):E82-E87.
PMID: 35036290
In patients with pancreatic cancer (PC), patient-derived organoid cultures can be useful tools for personalized drug selection and preclinical evaluation of novel therapies. To establish a less invasive method of...
5.
Ogawa H, Nakahira S, Inoue M, Irei T, Hasegawa M, Kato K, et al.
Surg Endosc
. 2019 Jul;
34(5):2113-2119.
PMID: 31321532
Background: Repeat liver resection is an effective treatment approach for patients with recurrent hepatocellular cell carcinoma (HCC). However, the surgical feasibility and oncological significance of repeat laparoscopic liver resection (r-LLR)...
6.
Oyama K, Nakahira S, Ogawa H, Kato K, Hasegawa M, To T, et al.
Surg Case Rep
. 2019 May;
5(1):74.
PMID: 31073708
Background: Anatomic variants of the biliary tree present challenges to surgical management during laparoscopic cholecystectomy and affect perioperative outcomes. An aberrant right hepatic duct connecting into the cystic duct is...
7.
Nishi H, Ohtake Y, Toh T, Himura H, Maki R, Mikami J, et al.
Gan To Kagaku Ryoho
. 2019 Jan;
45(13):2342-2344.
PMID: 30692458
A 57-year-old female underwent abdominoperineal resection for rectal cancer. Although she received postoperative adjuvant chemotherapy, she had presacral recurrence with pain 26 months postoperatively. We provided palliative care in parallel...
8.
Ogawa H, Nakahira S, Kishimoto T, Kato K, Hasegawa M, Oyama K, et al.
Asian J Endosc Surg
. 2018 Jul;
12(3):344-347.
PMID: 30015378
Extra-adrenal paraganglioma is a rare form of neuroendocrine neoplasm capable of catecholamine secretion. The surgical risks associated with the tumor location are compounded in this case of a kyphotic patient....
9.
Ogawa H, Konno M, Kawamoto K, Nishida N, Koseki J, Mizushima T, et al.
Biomed Rep
. 2018 May;
8(5):497-499.
PMID: 29732151
Fetal cells in the developmental stages function with a distinct mechanism in comparison to adult tissues, which may be a useful source for regenerative medicine in postnatal medicine; however, the...
10.
Wada H, Eguchi H, Noda T, Ogawa H, Yamada D, Tomimaru Y, et al.
Surgery
. 2016 Jul;
160(5):1227-1235.
PMID: 27395761
Background: Several reports have suggested that hepatic resection provides a survival benefit in patients with hepatocellular carcinoma (HCC) at the intermediate stage of the Barcelona Clinic Liver Cancer classification (BCLC-B)....